Switch Automation and Berkeley Lab Advance Next Generation of Smart Buildings—From Analytics to Autonomous Operations Switch Automation, a global provider of smart building software, today announced the release of new product capabilities in Switch OpX (Operational Excellence), developed in collaboration…
Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients…
Cartherics and Catalent Expand Commercial License Agreement Cartherics Pty Ltd, a biotechnology company developing off‑the‑shelf immune cell therapies for high‑impact women’s diseases, including ovarian cancer and endometriosis, and Catalent, Inc., the leader in enabling the development and supply of better…
Infleqtion and NASA Deliver Next-Generation Quantum Capabilities to International Space Station Infleqtion a global leader in quantum computing and quantum sensing powered by neutral-atom technology, is providing upgraded quantum hardware to the International Space Station (ISS) via NASA’s Northrop Grumman-24 (NG-24)…
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Pulse Biosciences, Inc. developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first…
Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts Clarametyx Biosciences, Inc. a clinical-stage biotechnology company developing immune-enabling therapies and vaccines to address biofilm-driven chronic respiratory disease, today announced two senior leadership positions within its executive team to support…
CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26 CorVista Health, a leader in noninvasive cardiovascular diagnostics, announced new data evaluating a physiologic signal–based machine-learning model for detecting cardiac ischemia.…
TruArc Partners Acquires North American Adhesives and Sealant Solutions Provider Matrix Adhesives Group TruArc Partners a private equity firm focused on middle-market investments in business services and specialty manufacturing, announced today that it has acquired Matrix Adhesives Group (“Matrix” or…
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session Corcept Therapeutics Incorporated a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the…
Bayer Crop Science Canada Redefines Canola Innovation With New “Advancing Better Canola” Initiative Bayer Crop Science Canada launches Advancing Better Canola (ABCs), an industry-wide initiative to challenge and redefine how it thinks about canola innovation in support of Canadian farmers.…
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne Almirall S.A. a global biopharmaceutical company dedicated to medical dermatology, is presenting a broad range of clinical and real‑world data across its portfolio…
Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group Turn Therapeutics, Inc. a clinical-stage dermatology company developing novel therapies for inflammatory skin diseases, today announced it has entered into a growth capital loan facility with Avenue…